Products are packed and if necessary repacked with utmost care and precaution, the purpose is to minimize shipment volume and discretion. Our organization name or anything else that would imply pharmaceutical contents of the package is never used in our shipments. The size of our packages is never larger than what would cause unnecessary suspicion. If the order is too large to fit one of these packages, the order will automatically be divided into two or more packages (always included in the S&H-charges). Shipments are made from various shipping points in different European countries.
Flutamide and 2-hydroxyflutamide have been found in vitro to inhibit CYP17A1 (17α-hydroxylase/17,20-lyase), an enzyme which is required for the biosynthesis of androgens.  In accordance, flutamide has been found to slightly but significantly lower androgen levels in GnRH analogue-treated male prostate cancer patients  and women with polycystic ovary syndrome .  As such, flutamide is a weak inhibitor of androgen biosynthesis.  However, the clinical significance of this action may be limited when flutamide is given without a GnRH analogue to non-castrated men, as the drug markedly elevates testosterone levels into the high normal male range via prevention of AR activation-mediated negative feedback on the hypothalamic–pituitary–gonadal axis in this context.